Blood agent

Results: 47



#Item
1FOR IMMEDIATE RELEASE: Contact: Agent-in-Charge Michelle ThourotorApril 4, 2016

FOR IMMEDIATE RELEASE: Contact: Agent-in-Charge Michelle ThourotorApril 4, 2016

Add to Reading List

Source URL: publicsafety.ohio.gov

Language: English - Date: 2016-04-04 08:50:07
2Sound / Medical ultrasonography / Medicine / Ultrasound / Waves / Microbubbles / Medical physics / Medical equipment / Contrast medium / Acoustics / High-intensity focused ultrasound / Medical ultrasound

RED BLOOD CELLS AS AN ULTRASOUND CONTRAST AGENT Ali H Dhanaliwala*, Alexander L Klibanov†, John A Hossack* *Department of Biomedical Engineering, Department of Medicine - †Cardiovascular Division University of Virgin

Add to Reading List

Source URL: www.vsgc.odu.edu

Language: English - Date: 2013-05-02 13:43:32
3RED BLOOD CELLS AS AN ULTRASOUND CONTRAST AGENT Ali H Dhanaliwala∗ , Alexander L Klibanov† , John A Hossack∗ ∗ Department  of Biomedical Engineering, † Department of Medicine - Cardiovascular Division

RED BLOOD CELLS AS AN ULTRASOUND CONTRAST AGENT Ali H Dhanaliwala∗ , Alexander L Klibanov† , John A Hossack∗ ∗ Department of Biomedical Engineering, † Department of Medicine - Cardiovascular Division

Add to Reading List

Source URL: www.vsgc.odu.edu

Language: English - Date: 2013-05-02 13:43:38
4FOR IMMEDIATE RELEASE: Contact: Agent-in-Charge Michelle ThourotorMay 19, 2016

FOR IMMEDIATE RELEASE: Contact: Agent-in-Charge Michelle ThourotorMay 19, 2016

Add to Reading List

Source URL: publicsafety.ohio.gov

Language: English - Date: 2016-05-24 06:33:24
5Hepatitis E Virus  Common Human Exposure Routes: •	  Disease Agent:

Hepatitis E Virus Common Human Exposure Routes: • Disease Agent:

Add to Reading List

Source URL: www.aabb.org

Language: English - Date: 2014-03-26 11:28:37
6Clinical Commissioning Policy: The use of Rituximab as a second line agent for the eradication of inhibitors in patients with Acquired Haemophilia Reference: NHS England xxx/x/x 1

Clinical Commissioning Policy: The use of Rituximab as a second line agent for the eradication of inhibitors in patients with Acquired Haemophilia Reference: NHS England xxx/x/x 1

Add to Reading List

Source URL: www.engage.england.nhs.uk

Language: English - Date: 2015-03-23 14:07:33
7Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Add to Reading List

Source URL: mesoblast.com

Language: English - Date: 2014-02-21 12:10:36
8Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients

Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients

Add to Reading List

Source URL: mesoblast.com

Language: English - Date: 2013-12-30 23:23:27
9Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Add to Reading List

Source URL: www.mesoblast.com

Language: English - Date: 2014-02-21 12:10:36
10Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients

Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients

Add to Reading List

Source URL: www.mesoblast.com

Language: English - Date: 2013-12-30 23:23:27